CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)

被引:0
|
作者
Uchio, Edward M. [1 ]
Li, Roger [2 ]
Steinberg, Gary [3 ]
Lamm, Donald [4 ]
Kamat, Ashish [5 ]
Packiam, Vignesh [6 ]
Anderson, Paul [7 ]
Ku, Ja Hyeon [8 ]
Chisamore, Michael [9 ]
McAdory, John [10 ]
Hnat, Nataliya [10 ]
Kim, Jee-Hyun [10 ]
Grandi, Paola [10 ]
Burke, James [10 ]
机构
[1] UCI, Irvine, CA USA
[2] Moffit Canc Ctr, Tampa, FL USA
[3] NYU Langone Hlth, New York, NY USA
[4] BCG Oncol, Phoenix, AZ USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[6] Univ Iowa Hlth Care, Iowa City, IA USA
[7] Royal Melbourne Hosp, Melbourne, Australia
[8] Seoul Natl Univ Hosp, Seoul, South Korea
[9] Merck, Rahway, NJ USA
[10] UCI, CaliforniaCG Oncol, Irvine, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
S21-4
引用
收藏
页码:1587 / 1587
页数:1
相关论文
共 50 条
  • [41] THE CRETOSTIMOGENE GRENADENOREPVEC EXPANDED ACCESS PROGRAM IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN
    Sarah, P. Psutka
    Sima, Porten
    Kristen, Scarpato
    Mary, Westerman
    Suzanne, Merrill
    Anne, Schuckman
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [42] Phase Ib study: APL-1202 (APL) in combination with Bacillus Calmette-Guerin (BCG) in recurrent non-muscle invasive bladder cancer (NMIBC).
    Sfakianos, John
    Shore, Neal D.
    Zhuang, John
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] SINGLE INSTILLATION OF MITOMYCIN C (MMC) PLUS BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Weiss, Brian
    Wein, Alan
    Malkowicz, S. Bruce
    Guzzo, Thomas
    JOURNAL OF UROLOGY, 2015, 193 (04): : E294 - E294
  • [44] LACTOCOCCUS LACTIS SECRETING ATTENUATED RECOMBINANT STAPHYLOCOCCAL ENTEROTOXIN B (RSEB) EXCEEDS BACILLUS CALMETTE-GUERIN (BCG) IN THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Reis, Leonardo
    Castilho, Mariana
    Mobilon, Cristiane
    da Silveira, Wanderley
    Azevedo, Vasco
    Favaro, Wagner
    JOURNAL OF UROLOGY, 2013, 189 (04): : E217 - E218
  • [45] FAILURE OF BACILLUS CALMETTE-GUERIN THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER: DEFINITION AND TREATMENT OPTIONS
    Gual Frau, Josep
    Palou, Joan
    Rodriguez, Oscar
    Parada, Ruben
    Breda, Alberto
    Villavicencio, Humberto
    ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (07): : 423 - 433
  • [46] NON-MUSCLE INVASIVE BLADDER CANCER SUBTYPES WITH DIFFERENTIAL RESPONSE TO INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT
    de Jong, Florus C.
    Laajala, Teemu D.
    Hoedemaeker, Robert F.
    Rinaldetti, Sebastien
    Jordan, Kimberley R.
    van der Made, Angelique C. J.
    Nieuwkamer, Bart
    van der Schoot, Deric K. E.
    Boeve, Egbert R.
    Janssen, Emiel A. M.
    Mahmoudi, Tokameh
    Boormans, Joost L.
    Theodorescu, Dan
    Costello, James C.
    Zuiverloon, Tahlita C. M.
    JOURNAL OF UROLOGY, 2022, 207 (05): : E77 - E77
  • [47] Non-muscle invasive bladder cancer subtypes with differential response to intravesical bacillus Calmette-Guerin treatment
    De, Jong F. C.
    Laajala, T. D.
    Hoedemaeker, R. F.
    Rinaldetti, S.
    Jordan, K.
    Van der Made, A. C. J.
    Nieuwkamer, B.
    Boeve, E. R.
    Janssen, E. A. M.
    Mahmoudi, T.
    Boormans, J. L.
    Theodorescu, D.
    Costello, J. C.
    Zuiverloon, T. C. M.
    EUROPEAN UROLOGY, 2022, 81 : S105 - S106
  • [48] Impact of bladder cancer family history on the prognosis of patients with non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)
    Abou Chakra, Mohamad
    Duquesne, Igor
    Peyromaure, Michael
    Mott, Sarah L.
    Moussa, Mohamad
    O'Donnell, Michael A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (03) : 315 - 324
  • [49] Urinary cytokine profiles reflect rationale for treatment with gemcitabine and Bacillus Calmette-Guerin (BCG) in BCG-exposed high-risk non-muscle invasive bladder cancer (NMIBC)
    Gaffney, Christopher D.
    Alam, Syed M.
    Lavery, Jessica A.
    Basar, Merve
    D'Souza, Neeta
    Hernandez, Christian
    McCarter, Melissa
    Moran, Patricia
    Stasi, Kristen
    Worth, Kara
    Sjoberg, Daniel
    Dalbagni, Guido
    Donahue, Timothy
    Donat, Sherri
    Bajorin, Dean
    Bochner, Bernard H.
    Goh, Alvin
    Sarungbam, Judy
    Al-Ahmadie, Hikmat
    Pietzak, Eugene J.
    CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [50] Outcomes of Patients with Bacillus Calmette-Guerin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer as Defined by the U.S. Food and Drug Administration
    Howard, Jeffrey M.
    Cook, Grayden S.
    Tverye, Aaron
    Nandy, Karabi
    Margulis, Vitaly
    Woldu, Solomon L.
    Lotan, Yair
    BLADDER CANCER, 2022, 8 (03) : 303 - 314